Patent ductus arteriosus
Pediculosis
Lice Control's Head Lice Removal Clinic Weighs in on Bay Area Head Lice Debate
[Press Release] PR Web - Feb 24 12:18 AM Lice Control's head lice removal services offer an answer to questions surrounding the current "No-Nit" policy debate. (PRWeb Feb 24, 2007) Post Comment:Trackback URL: http://www.prweb.com/dingpr.php/Q291cC1UaGlyLVN1bW0tSG9yci1NYWduLVplcm8=
Pelvic inflammatory disease
Young women risk chlamydia more than once: study
Reuters via Yahoo! News - 56 minutes ago Young women risk being infected with chlamydia more than once, researchers reported on Tuesday in a series of studies showing just how vulnerable younger women are to the disease.
Pemphigus vulgaris
Aspreva Pharmaceuticals reports first quarter 2006 results
T-Net British Columbia - Apr 27 8:21 AM Vancouver, BC, April 27, 2006--(T-Net)--Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV; TSX: ASV), an emerging pharmaceutical company focused on increasing the pool of evidence-based medicines for patients with less common diseases, today reported business and financial results for the first quarter ended March 31, 2006. Total revenues in the first quarter were $62.7 million with net income of
Pendred syndrome
Periodontal disease
Peptide Inhibitor May Prevent Bone Loss In Osteoporosis
Medical News Today - May 09 7:02 AM Two molecules known as RANK and TNFR promote the differentiation of osteoclasts - cells that are responsible for the breakdown of bone. This process occurs in healthy individuals - as part of the constant renewal of the bone that makes up our skeleton, and it occurs at an increased rate in individuals with diseases such as osteoporosis, rheumatoid arthritis, and periodontal disease... click link
Periodontitis
Ondine Announces Periowave(TM) Photodisinfection Data Published in The Journal of Clinical Dentistry(R)
[Press Release] CNW Group via Yahoo! Finance - 2 hours, 41 minutes ago Ondine Biopharma Corporation today announced the publication of a peer-reviewed research paper in the April 2007 issue of Journal of Clinical Dentistry entitled, "Treatment of Periodontal Disease by Photodisinfection Compared to Scaling and Root Planing".
Peripheral neuropathy
Quigley Pharma Scheduled to Commence Clinical Testing of QR-333, Its Topical Diabetic Peripheral Neuropathy
[Press Release] PR Newswire via Yahoo! Finance - May 09 4:00 AM Quigley Pharma, a wholly-owned subsidiary of The Quigley Corporation , announced today that it has begun screening patients to start testing their investigational new drug QR-333. Starting May 15th, patients suffering from diabetic peripheral neuropathy will be given doses in an escalating fashion to provide pharmacokinetics data.
Peritonitis
Questions on whale shark's death linger
Atlanta Journal-Constitution - Mar 31 12:10 AM A day after the Georgia Aquarium released test results showing that Ralph, its famous whale shark, died of peritonitis earlier this year, questions remain about what caused a deadly perforation in his stomach, and critics again blasted the institution for trying to display the giant creatures in captivity. Jeff Swanagan, Georgia Aquarium's president and executive director, insists that Ralph got ...
Pernicious anemia
Confusion surrounds B-12 deficiency
Bradenton Herald - Apr 20 12:35 PM Tired and run down? No appetite? Trouble walking? Depressed or irritable? Do your hands or feet tingle?
Persistent sexual arousal syndrome
Some Women Suffer From Disruptive Orgasm Disease
CBS 13 Sacramento - May 02 8:52 PM 54 year old Jean Lund is packing for a plane ride, a plane ride that will make her uncomfortable, irritable and put her in pain.
Pertussis
MainHeadWhoops! Better get your pertussis booster vaccine
The Standard-Times - Mar 30 8:04 PM Would you get a vaccine that could protect you from a disease that makes you cough so hard you vomit, lose control of your bladder, or even break your ribs or make you faint?
Peyronie disease
Auxilium Pharmaceuticals, Inc. Announces First Quarter 2006 Financial Results
[Press Release] PR Newswire via Yahoo! Finance - May 09 4:30 AM Auxilium Pharmaceuticals, Inc. , a specialty pharmaceutical company, today announced financial results for the quarter ended March 31, 2006. For the first quarter of 2006, Auxilium reported net revenues of $14.9 million compared to net revenues of $8.8 million in the first quarter of 2005.
Phenylketonuria
Research and Markets: The Oxford Handbook of Nutrition and Dietetics, First Edition, Covers the Entire Life Cycle from ...
[Press Release] Business Wire via Yahoo! Finance - Mar 27 5:01 AM DUBLIN, Ireland----Research and Markets has announced the addition of Oxford Handbook of Nutrition and Dietetics, First Edition to their offering. Practical and concise quick reference guide to nutrition and dietetics Covers the entire life cycle from preconception to old age Includes nutritional science which underpins the application of nutrition in public health and therapeutic situations ...
Pheochromocytoma
Widely Used Iron Nanoparticles Exhibit Toxic Effects On Nerve Cells
Science Daily - Mar 28 2:07 PM Iron-containing nanoparticles that are being tested for several biomedical applications can be toxic to nerve cells, interfering with the formation of their signal-transmitting extensions.
Photosensitive epilepsy
Pica
Area deaths
The Palm Beach Post - Apr 01 9:29 PM Palm Beach County
Pilonidal cyst
Pinta
Farmers Snap Working Year for New Exhibition
RedNova - Mar 29 11:16 AM By Linda McKee The exhibition, launched this week by the Dairy Council for Northern Ireland, showcases a year in the life of a dairy farm in a series of photos taken by Ulster farmers and their families during 2005/06.
PIRA
RESTAURANTS CAN BOTTLED WATER
San Jose Mercury News - Apr 01 2:23 AM Bye-bye bottled water. Hello eau de tap. A new trend is in the pipeline, with some upscale restaurants ditching packaged H2O in the name of conservation.
Placental abruption
Salt reduction 'not beneficial' during pregnancy
Food Navigator - May 05 3:57 AM 05/05/2006 - Recent scientific research does not support the common assumption that women should lower their salt intake during pregnancy to reduce the risks for developing pre-eclampsia or oedema, according to a recent forum.
Plague
Musical beginnings and medieval endings in Poland
USA Today - 2 hours, 9 minutes ago What happened: Flight headaches continued to plague teams this week's double-leg race from Zanzibar, Tanzania, to Warsaw, Poland. Delays, communication problems and missed connections meant that some teams began the next leg of the race before others even arrived in...
Pleural effusion
OncoGenex Announces Encouraging Data from a Phase I Study of Patients with Non-Small Cell Lung Cancer
T-Net British Columbia - May 04 9:07 AM Vancouver, BC, May 4, 2006--(T-Net)--OncoGenex Technologies Inc. today announced encouraging results from a Phase I study evaluating systemic administration of OGX-011 in combination with standard chemotherapy agents, gemcitabine and cisplatin, in patients with non-small cell lung cancer (NSCLC).
Pleuritis
Pneumoconiosis
Guardian Technologies' Negotiating Joint Collaboration Agreements for Its Healthcare Signature Mapping(TM) Technology
[Press Release] Business Wire via Yahoo! Finance - Mar 23 5:44 AM HERNDON, Va.----Guardian Technologies International, Inc. , a leading technology developer of intelligent imaging informatics solutions for the homeland security and healthcare sectors, is actively engaged in negotiations with two privately-held companies to collaboratively integrate Guardian's Signature Mapping technology into their existing products, and to be developed products, and to market ...
Pneumothorax
'Lung Endometriosis is Life Threatening and can be Fatal,' Says Glynis Wallace, DMD, Author, Living with Lung and Colon ...
[Press Release] PRWeb via Yahoo! News - Apr 04 12:01 AM The truth about Lung Endometriosis is incontrovertible -- malice may attack it, ignorance may deride it, but in the end, you are forced to face it.
All Categories
Symptoms Treatment Al to An Symptoms Treatment An to Ar Symptoms Treatment As to Bi Symptoms Treatment Bl to Be Symptoms Treatment Bu to Ce Symptoms Treatment Ce to Cl Symptoms Treatment Cl to Cr Symptoms Treatment Cr to Di Symptoms Treatment Di to Em Symptoms Treatment En to Fa Symptoms Treatment Fa to Gi Symptoms Treatment Gi to He Symptoms Treatment He to Hi Symptoms Treatment Hi to Hp Symptoms Treatment Hy to Ja Symptoms Treatment Jo to Lu Symptoms Treatment Lg to Me Symptoms Treatment Me to My Symptoms Treatment My to Os Symptoms Treatment Os to Pa Symptoms Treatment Pa to Pn Symptoms Treatment Po to Co Symptoms Treatment Pr to Qf Symptoms Treatment Ra to Sc Symptoms Treatment Si to Ap Symptoms Treatment Pi to St Symptoms Treatment St to Tr Symptoms Treatment Th to Va Symptoms Treatment Va to Wi
|
|
Patent ductus arteriosus
| Patent ductus arteriosus
|
| ICD-10 code:
| Q25.0
|
| ICD-9 code:
| 747.0
|
Patent ductus arteriosus (PDA) is a congenital heart defect wherein a child's ductus arteriosus fails to close after birth. Symptoms include shortness of breath and cardiac arrhythmia, and may progress to congestive heart failure if left uncorrected.
Contents
- 1 Overview
- 1.1 Normal ductus arteriosus closure
- 1.2 Patent ductus arteriosus
- 2 Signs and symptoms
- 3 Diagnosis
- 4 Treatment
- 5 External links
|
Overview
Normal ductus arteriosus closure
In the developing fetus, the ductus arteriosus (DA) is a shunt connecting the pulmonary artery to the aortic arch that allows much of the blood from the right ventricle to bypass the fetus' fluid-filled lungs. During fetal development, this shunt protects the lungs from being overworked and allows the right ventricle to strengthen.
When the newborn takes its first breath, the lungs open and pulmonary pressure decreases below that of the left heart. At the same time, the lungs release bradykinin to constrict the smooth muscle wall of the DA and reduce bloodflow. Additionally, because of reduced pulmonary resistance, more blood flows from the pulmonary arteries to the lungs and thus the lungs deliver more oxygenated blood to the left heart. This further increases aortic pressure so that blood no longer flows from the pulmonary artery to the aorta via the DA.
In normal newborns, the DA is closed within 15 hours after birth, and is completely sealed after three weeks. A nonfunctional vestige of the DA, called the ligamentum arteriosum, remains in the adult heart.
Patent ductus arteriosus
In PDA, the newborn's ductus arteriosus does not close, but remains patent. Patent DA is common in infants with persistent respiratory problems such as hypoxia, and has a high occurrence in premature children. In hypoxic newborns, too little oxygen reaches the lungs to produce sufficient levels of bradykinin and subsequent closing of the DA. Premature children are more likely to be hypoxic and thus have PDA because of their underdeveloped heart and lungs.
A patent ductus arteriosus allows oxygenated blood to flow down its pressure gradient from the aorta to the pulmonary arteries. Thus, some of the infant's oxygenated blood does not reach the body, and the infant becomes short of breath and cyanotic. The heart rate hastens, thereby increasing the speed with which blood is oxygenated and delivered to the body. Left untreated, the infant will likely suffer from congestive heart failure, as his heart is unable to meet the metabolic demands of his body.
Signs and symptoms
While some cases of PDA are asymptomatic, common symptoms include:
- tachycardia or other arrhythmia
- respiratory problems
- shortness of breath
- heart murmur
- enlarged heart
- cyanosis
Diagnosis
PDA is usually diagnosed using non-invasive techniques. Electrocardiography (ECG), in which electrodes are used to record the electrical activity of the heart, can be used to detect cardiac arrhythmias associated with PDA.
A chest X-ray may be taken, which reveals the structure of the infant's heart and the size and configuration of its chambers. In some instances, the X-ray itself may reveal a patent ductus arteriosus.
Echocardiography, in which sound waves are used to capture the motion of the heart, is also useful in detecting PDA.
Treatment
Both surgical and non-surgical methods of treatment are available. Surgically, the DA may be closed by ligation, wherein the DA is manually tied shut, or with intravascular coils that physically constrict the DA.
Fluid restriction and prostaglandin inhibitors such as indomethacin have also been used in successful non-surgical closure of the DA. This is an especially viable alternative for premature infants.
External links
- MedlinePlus Medical Encyclopedia: Patent ductus arteriosus (including diagram)
- High-Risk Newborn - Patent Ductus Arteriosus (PDA)
- Fetal Circulation
- Fetal blood flowde:Ductus arteriosus
Search Term: "Patent_ductus_arteriosus"
Categories: Congenital heart disease |
|